MKI67 and neoplasm: To assess the proliferative capacity of DsRed+ and GFP+ cells in tumors, we immunofluorescently labeled tumor tissue sections with Ki67, which marks cells in active phases of the cell cycle (Bruno and Darzynkiewicz, 1992).